Aristotle Atlantic's Core Equity Q4 2024 Commentary
Aristotle Atlantic’s Core Equity Composite posted a total return of 4.11% gross of fees (4.00% net of fees). Click here to ...
Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023 Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023 Full year 2024 total ...
Blue Origin CEO says he's trimming middle managers after rapid hiring led to 'more bureaucracy.' Read the memo.
Blue Origin CEO David Limp told employees in an email that there was "less focus" at the rocket company than it needs to ...
News 80006d
Tall tales and little transparency drive Trump and Musk’s US government wrecking ball
The Mack truck Elon Musk and President Donald Trump are driving through the government as we know it is fueled by some stories that aren’t true, but fester ...